FDA approves Doptelet for liver disease patients undergoing procedures
May 22, 2018
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure.
Controversy surrounds calf vein thrombosis treatment
January 30, 2018
CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.
Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk
December 6, 2017
The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.
Infections increase risk of idiopathic VTE
November 8, 2017
Beware the increased risk of VTE in patients with infections.
Atrial fibrillation boosts VTE risk
October 31, 2017
BARCELONA – Study shows women face higher and more persistent risk.
Caprini score is not a good predictor of PE in patients with DVT
October 25, 2017
Commonly used model failed to predict pulmonary embolism in patients with DVT.
Wait at least 2 days to replace central venous catheters in patients with candidemia
October 15, 2017
SAN DIEGO – It likely will reduce 30-day mortality.
Oral anticoagulation ‘reasonable’ in advanced kidney disease with A-fib
October 5, 2017
Reduced stroke risk, no increase in bleeding in atrial fibrillation and advanced chronic kidney disease.
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
October 2, 2017
Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.
Idle intravenous catheters are associated with preventable complications
December 15, 2016
Intravenous catheters are common and necessary for inpatient care, but peripheral – and especially central venous – catheters are associated with increased risk for local and systemic complications.